...
首页> 外文期刊>Journal of glaucoma >Comparison of Surgical Outcomes Between Phacocanaloplasty and Phacotrabeculectomy at 12 Months' Follow-up: A Longitudinal Cohort Study
【24h】

Comparison of Surgical Outcomes Between Phacocanaloplasty and Phacotrabeculectomy at 12 Months' Follow-up: A Longitudinal Cohort Study

机译:术后12个月随访行眼睑成形术和小梁切除术手术结果的比较:一项纵向队列研究

获取原文
获取原文并翻译 | 示例

摘要

Purpose:To compare operative outcomes of patients after phacocanaloplasty and phacotrabeculectomy through 12 months' follow-up.Design:Retrospective, nonrandomized, comparative case series.Materials and Methods:We included 36 eyes of 36 patients with open-angle glaucoma who underwent combined phacoemulsification and canaloplasty (phacocanaloplasty) and 41 eyes of 41 patients with open-angle glaucoma who underwent combined phacoemulsification and trabeculectomy with mitomycin C (phacotrabeculectomy) with 12 months' of postoperative follow-up. All surgeries were performed by a single surgeon (R.S.A.) between January 2007 and May 2011.Main Outcome Measures:Failure was based on intraocular pressure (IOP; >18 or <4 mm Hg at 1 y), second operative procedure (any eye requiring reoperation), or decrease in visual acuity by 0.20 logMAR. Change in IOP, visual acuity (VA), glaucoma medications, and complication rates at 12 months were analyzed.Results:There were no differences in demographics other than the sex between the groups. There were also no significant differences in previous surgery or in preoperative VA, IOP, or use of glaucoma medications between the groups, though the phacotrabeculectomy group had a higher preoperative IOP at baseline and a larger SD. Both groups showed significant reduction in IOP from baseline at every time point (P<0.001). No significant difference in mean IOP at 12 months was found, with a mean of 14.14.4 mm Hg in the phacocanaloplasty group and 11.85.4 mm Hg in the phacotrabeculectomy group (P=0.07). The phacotrabeculectomy group showed a significantly greater median absolute (8 vs. 5 mm Hg) and percent (40% vs. 28%) reduction in IOP at 12 months (P=0.02). Postoperative glaucoma medication use was similar between the 2 groups.Overall failure rates at 1 year were comparable between the 2 groups: 22% for phacocanaloplasty versus 20% for phacotrabeculectomy (P=0.79). Phacotrabeculectomy eyes experienced more visual failures (5% vs. 0%, P=0.50), whereas phacocanaloplasty experienced more IOP failures (17% vs. 12%, P=0.75). No difference in operative failure rate was found between the phacocanaloplasty and phacotrabeculectomy groups (6% vs. 5%, P=1.00) and this held after controlling for covariates. Final VA was not statistically different between the 2 groups.Conclusions:Phacocanaloplasty and phacotrabeculectomy both achieved significant reduction in IOP and improvement in VA at 12 months with comparable success rates. Phacotrabeculectomy achieved a statistically greater median percentage decrease in IOP, but the 2 procedures resulted in comparable mean IOP at 12 months.
机译:目的:比较12个月随访行超声乳化白内障摘除术和超声乳化小梁切除术后患者的手术结果设计:回顾性,非随机,比较病例系列材料和方法:我们纳入了36例开角型青光眼患者行联合超声乳化术的36只眼。 41例开角型青光眼患者的41眼和泪管成形术(phacocanaloplasty)接受了超声乳化和小梁切除术联合丝裂霉素C(超声小梁切除术),术后随访12个月。所有手术均由一名外科医生(RSA)在2007年1月至2011年5月之间进行。主要观察指标:失败是基于眼压(IOP;在1 y时> 18或<4 mm Hg),第二次手术(需要任何眼睛)重新手术),或视力降低0.20 logMAR。分析了12个月时的眼压,视敏度(VA),青光眼用药和并发症发生率的变化。结果:两组之间的人口统计学差异无性别差异。各组之间的既往手术或术前VA,IOP或青光眼药物的使用也无显着差异,尽管超声小梁切除术组的术前IOP较高,SD较大。两组在每个时间点的眼压均显着降低(P <0.001)。 12个月时的平均眼压没有显着差异,白内障成形术组平均为14.14.4 mm Hg,白内障摘除术组的平均IOP为11.85.4 mm Hg(P = 0.07)。晶状体小梁切除术组显示12个月时IOP的中值绝对值(8 vs. 5 mm Hg)明显降低,百分比降低(40%vs. 28%)(P = 0.02)。两组术后青光眼的用药情况相似,两组在1年时的总失败率相当:白内障成形术为22%,白内障小梁切除术为20%(P = 0.79)。角膜小梁切除术的眼睛经历了更多的视力衰竭(5%vs. 0%,P = 0.50),而白内障成形术经历了更多的IOP失败(17%vs. 12%,P = 0.75)。白内障成形术组和白内障小梁切除术组之间的手术失败率没有差异(6%vs. 5%,P = 1.00),并且在控制了协变量后仍保持这一水平。两组之间的最终VA没有统计学差异。结论:在12个月时,行眼睑成形术和超声乳化小梁切除术均实现了IOP的显着降低和VA的改善,成功率相当。眼睑小梁切除术的眼压降低中位数百分比在统计学上更高,但两种手术在12个月时的平均眼压均相当。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号